BACKGROUND: The first COVID-19 vaccine outside a clinical trial setting was administered on Dec 8, 2020. However, inadequate access to vaccines in low-income countries has limited the impact in these settings, reinforcing the need for global vaccine equity and coverage.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Jun 23, 2022 |
| Journal | The Lancet Infectious Diseases |
| Authors | Oliver J. Watson, Gregory Barnsley, Jaspreet Toor, Alexandra B. Hogan, Peter Winskill |
| DOI | 10.1016/s1473-3099(22)00320-6 |
| Citations | 1,826 |
| Source | OpenAlex |